Bayer AG (XSWX:BAYN) Cyclically Adjusted Revenue per Share: CHF47.79 (As of Mar. 2026)


XSWX:BAYN Bayer AG XSWX:BAYN
54 GF Score
Price CHF43.29
GF Value CHF24.61
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bayer AG Cyclically Adjusted Revenue per Share?

Bayer AG XSWX:BAYN +1.88% 54 Cyclically Adjusted Revenue per Share is CHF47.79 as of Mar. 2026. GuruFocus rates XSWX:BAYN with a GF Score™ of 54/100 and a GF Value™ of CHF24.61 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bayer AG's adjusted revenue per share for the three months ended in Mar. 2026 was CHF12.419. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF47.79 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bayer AG's average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bayer AG was 3.90% per year. The lowest was -0.60% per year. And the median was 2.10% per year.

As of today (2026-07-01), Bayer AG's current stock price is CHF43.29. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was CHF47.79. Bayer AG's Cyclically Adjusted PS Ratio of today is 0.91.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 2.52. The lowest was 0.35. And the median was 1.08.


Bayer AG  (XSWX:BAYN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=43.29/47.79
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 2.52. The lowest was 0.35. And the median was 1.08.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bayer AG Cyclically Adjusted Revenue per Share Related Terms


Bayer AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bayer AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Cyclically Adjusted Revenue per Share Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 213.49 222.00 0.00 0.00 0.00

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 47.79

XSWX:BAYN vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.


XSWX:BAYN
54GF Score
Bayer AG XSWX:BAYN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=12.419/131.2583*131.2583
=12.419

Current CPI (Mar. 2026) = 131.2583.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 15.587 100.717 20.314
201609 10.907 101.017 14.172
201612 11.173 101.217 14.489
201703 11.899 101.417 15.400
201706 10.708 102.117 13.764
201709 10.396 102.717 13.285
201712 11.338 102.617 14.503
201803 12.062 102.917 15.384
201806 11.975 104.017 15.111
201809 10.676 104.718 13.382
201812 11.916 104.217 15.008
201903 14.132 104.217 17.799
201906 12.182 105.718 15.125
201909 10.916 106.018 13.515
201912 11.947 105.818 14.819
202003 13.859 105.718 17.207
202006 10.963 106.618 13.497
202009 9.330 105.818 11.573
202012 10.996 105.518 13.678
202103 13.890 107.518 16.957
202106 12.084 108.486 14.621
202109 10.809 109.435 12.965
202112 11.777 110.384 14.004
202203 15.252 113.968 17.566
202206 13.382 115.760 15.174
202209 11.066 118.818 12.225
202212 12.054 119.345 13.257
202303 14.513 122.402 15.563
202306 10.966 123.140 11.689
202309 10.107 124.195 10.682
202312 11.387 123.773 12.076
202403 13.533 125.038 14.206
202406 10.914 125.882 11.380
202409 9.541 126.198 9.924
202412 11.146 127.041 11.516
202503 13.358 127.779 13.722
202506 10.253 128.412 10.480
202509 9.188 129.255 9.330
202512 10.864 129.361 11.023
202603 12.419 131.258 12.419

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CHF47.79 mean?
Bayer AG (XSWX:BAYN) has a Cyclically Adjusted Revenue per Share of CHF47.79 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bayer AG and its competitors.
Is Bayer AG's Cyclically Adjusted Revenue per Share too high?
Bayer AG's current Cyclically Adjusted Revenue per Share is CHF47.79. Overall, Bayer AG has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
Bayer AG's Cyclically Adjusted Revenue per Share of CHF47.79 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bayer AG and its competitors. Bayer AG's current Cyclically Adjusted Revenue per Share is CHF47.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (XSWX:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF24.61, compared to a current price of CHF43.29 — trading 75.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is CHF47.79. Bayer AG's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bayer AG (XSWX:BAYN), the current Cyclically Adjusted Revenue per Share is CHF47.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (XSWX:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of CHF43.29 is trading 75.9% above its estimated GF Value™ of CHF24.61. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for XSWX:BAYN:

  • Cyclically Adjusted Revenue per Share: CHF47.79
  • GF Value™: CHF24.61 vs. price of CHF43.29 (75.9% above fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the XSWX:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
54GF Score

Get the complete analysis for XSWX:BAYN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF43.29
Price
CHF24.61
GF Value